Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy
2024 · Signal Transduction and Targeted Therapy · 331 citations
https://doi.org/10.1038/s41392-024-01953-7
J
Jianpeng Sheng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
71
Papers
2.1K
Citations
20
h-index
30
i10-index
Jianpeng Sheng is an academic researcher from Capital Medical University. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Cholangiocarcinoma and Gallbladder Cancer Studies & RNA modifications and cancer. The author has an h-index of 20, co-authored 61 publications.
ORCID: 0000-0002-5535-5541Papers by this author
worksOrgan-Specific Fate, Recruitment, and Refilling Dynamics of Tissue-Resident Macrophages during Blood-Stage Malaria
2018 · Cell Reports · 77 citations
https://doi.org/10.1016/j.celrep.2018.11.059
Circumventing drug resistance in gastric cancer: A spatial multi-omics exploration of chemo and immuno-therapeutic response dynamics
2024 · Drug Resistance Updates · 56 citations
https://doi.org/10.1016/j.drup.2024.101080
Multi-omics analysis reveals the chemoresistance mechanism of proliferating tissue-resident macrophages in PDAC via metabolic adaptation
2023 · Cell Reports · 44 citations
https://doi.org/10.1016/j.celrep.2023.112620
Runx3-overexpression cooperates with ex vivo AKT inhibition to generate receptor-engineered T cells with better persistence, tumor-residency, and antitumor ability
2023 · Journal for ImmunoTherapy of Cancer · 25 citations
https://doi.org/10.1136/jitc-2022-006119
Breakthroughs in treatment for hematological malignancies: latest updates on molecular glue, PROTACs and RNA degraders from ASH 2024
2025 · Journal of Hematology & Oncology · 14 citations
https://doi.org/10.1186/s13045-025-01674-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat